Concepedia

Suravi Chakrabarty

SC

Statistics

Publications

8

Citations

254

H-Index

8

Active since

1992

Affiliations

Duquesne University(Current)

Tulane University

KU Leuven

Tulane Medical Center

Suravi Chakrabarty is an author at Duquesne University specializing in signal transduction, pharmacology, and oncology.

ORCID

Publications per year

1992–2021

8

Publications

8

Catalytic Isonitrile Insertions and Condensations Initiated by RNC–X Complexation

Suravi Chakrabarty, Shruti Choudhary, Arpit Doshi et al. · Advanced Synthesis & Catalysis · 2014 · 140 citations

, , +16

Pharmacological inhibition of the MEK5/ERK5 and PI3K/Akt signaling pathways synergistically reduces viability in triple‐negative breast cancer

Thomas D. Wright, Christopher Raybuck, Akshita B. Bhatt et al. · Journal of Cellular Biochemistry · 2019 · 27 citations · Full text

, , +17

Controlled Inhibition of Apoptosis by Photoactivatable Caspase Inhibitors

Suravi Chakrabarty, Steven H. L. Verhelst · Cell chemical biology · 2020 · 18 citations · Full text

, , +12

Novel Diphenylamine Analogs Induce Mesenchymal to Epithelial Transition in Triple Negative Breast Cancer

Akshita B. Bhatt, Mohit Gupta, Van T. Hoang et al. · Frontiers in Oncology · 2019 · 17 citations · Full text

, , +17

Diverse and converging roles of ERK1/2 and ERK5 pathways on mesenchymal to epithelial transition in breast cancer

Akshita B. Bhatt, Thomas D. Wright, Van Barnes et al. · Translational Oncology · 2021 · 17 citations · Full text

, , +17

1–5 of 8